spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

3rd Annual Inhalation & Respiratory Drug Delivery Congress

8-9 May 2018
London, UK

Oxford Global are proud to present our hugely popular 3rd Annual Inhalation & Respiratory Drug Delivery Congress, 8th – 9th May 2018, London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 20 presentations and case studies focused on the key issues in inhalation and respiratory drug delivery.

Including 2 interactive streams:

  • Development and Formulation of Inhaled Therapies
  • Inhalation Devices and Analytics

Co-located with the 

4th Annual Formulation & Drug Delivery Congress 

View the Agenda here:

http://bit.ly/2BepVvV

Free Pre-Congress Webinar Recordings

Inhaled Insulin: Highway to Heaven or Road to Ruin?
Jim Fink, Senior Fellow Clinical Aerosol Product Development, Dance Biopharm

Download today for free:

http://bit.ly/2ze1woR

Stratification and Considerations for DPI Development

Sven Stegemann, Professor, Graz University of Technology

Download today for free:

http://bit.ly/2ze1woR

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>


News and Press Releases

BioIVT to Focus on the Application of In Vitro Hepatocyte Models in Toxicology Research at the North American ISSX Meeting

BioIVT, a leading provider of research models and services for drug development, today announced that it will be participating in several sessions at the 22nd North American International Society for the Study of Xenobiotics (ISSX) Meeting. This conference will be held from July 15-19 at the Palais des congrès de Montréal in Montréal, Canada.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement